These individuals were first described by Ruderman et al. as hyperinsulinemic, insulin resistant, hypertriglyceridemic, and predisposed to subsequent development of type 2 diabetes mellitus and coronary artery disease (179). The gene discussed is INS; the disease is diabetes mellitus.